Patient-reported outcomes (PROs) are increasingly being incorporated into clinical trial design, which has led to advances that benefit patients.
Healthcare practitioners can now tell their patients with stage III colon cancer that eating tree nuts (eg, walnuts, almonds, hazelnuts, cashews, and pecans) and maintaining a healthy lifestyle can improve their chances of overall survival as well as recurrence-free survival.
A brief, Internet-based psychological intervention improved quality of life, reduced fatigue, and reduced distress levels in patients with newly diagnosed cancer.
Hair loss is a well-known side effect of chemotherapy, but alopecia can also occur with endocrine therapy.
Long-term, regular use of aspirin was associated with reduced risk for death from any cause, as well as death from cancer, in a very large observational study reported at the 2017 Annual Meeting of the American Association for Cancer Research.
Unanticipated cardiotoxicity occurs in an estimated 3.5% of patients with hematologic malignancies secondary to the use of targeted therapies.
The United States may be in the midst of an opioid epidemic, but the undertreatment of pain remains an issue for patients with cancer.
Although transplantation offers cures or durable remissions for malignancies, relapse is a frequent occurrence in many diseases, and remains a major cause of mortality.
Despite significant progress in stem-cell transplantations over the past decade, graft-versus-host disease (GVHD) remains the leading cause of nonrelapse death in this patient population.
Precision medicine con­tinues to transform oncology, and it is not just the treatments that are changing.
Page 1 of 44
Results 1 - 10 of 434